These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15782277)

  • 1. Prophylactic use of antibiotics for prevention of meningococcal infections: systematic review and meta-analysis of randomised trials.
    Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Eur J Clin Microbiol Infect Dis; 2005 Mar; 24(3):172-81. PubMed ID: 15782277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotics for preventing meningococcal infections.
    Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004785. PubMed ID: 15674966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics for preventing meningococcal infections.
    Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004785. PubMed ID: 17054214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotics for preventing meningococcal infections.
    Zalmanovici Trestioreanu A; Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2011 Aug; (8):CD004785. PubMed ID: 21833949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics for preventing meningococcal infections.
    Zalmanovici Trestioreanu A; Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004785. PubMed ID: 24163051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In brief: Meningococcal prophylaxis.
    Med Lett Drugs Ther; 2008 Apr; 50(1283):25. PubMed ID: 18391897
    [No Abstract]   [Full Text] [Related]  

  • 7. A systematic review and meta-analysis on the antibiotic resistance of Neisseria meningitidis in the last 20 years in the world.
    Rostamian M; Chegene Lorestani R; Jafari S; Mansouri R; Rezaeian S; Ghadiri K; Akya A
    Indian J Med Microbiol; 2022; 40(3):323-329. PubMed ID: 35654713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis sequence type 4821: The first case in Japan.
    Kawasaki Y; Matsubara K; Takahashi H; Morita M; Ohnishi M; Hori M; Isome K; Iwata A; Nigami H; Ikemachi M; Yamamoto G; Ohkusu K
    J Infect Chemother; 2018 Apr; 24(4):305-308. PubMed ID: 29233459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis for meningococcal disease.
    Artenstein MS
    JAMA; 1975 Mar; 231(10):1035-7. PubMed ID: 803581
    [No Abstract]   [Full Text] [Related]  

  • 10. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Feb; 46(RR-5):1-10. PubMed ID: 9048846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampin-resistant meningococcal disease.
    Rainbow J; Cebelinski E; Bartkus J; Glennen A; Boxrud D; Lynfield R
    Emerg Infect Dis; 2005 Jun; 11(6):977-9. PubMed ID: 15963302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
    Nelson RL; Kelsey P; Leeman H; Meardon N; Patel H; Paul K; Rees R; Taylor B; Wood E; Malakun R
    Cochrane Database Syst Rev; 2011 Sep; (9):CD004610. PubMed ID: 21901692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Have South Australian isolates of Neisseria meningitidis become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971-1999.
    Hansman D; Wati S; Lawrence A; Turnidge J
    Pathology; 2004 Apr; 36(2):160-5. PubMed ID: 15203752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal disease. Secondary attack rate and chemoprophylaxis in the United States, 1974.
    JAMA; 1976 Jan; 235(3):261-5. PubMed ID: 811822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alternating rifampicin and ceftriaxone for Neisseria meningitidis eradication in contacts].
    Shehab S; Leitner L; Bogokowsky B; Epstein I; Swartz TA
    Harefuah; 1991 Jun; 120(11):641-3. PubMed ID: 1937208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
    Sharma SK; Sharma A; Kadhiravan T; Tharyan P
    Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of fluoroquinolone-resistant Neisseria meningitidis--Minnesota and North Dakota, 2007-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(7):173-5. PubMed ID: 18288075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of resistance to rifampicin in clinical isolates of Neisseria meningitidis.
    Skoczynska A; Ruckly C; Hong E; Taha MK
    Clin Microbiol Infect; 2009 Dec; 15(12):1178-81. PubMed ID: 19456827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Susceptibility to antimicrobial drugs used in the prophylaxis of meningococcal disease: situation after an epidemic wave].
    Arreaza L; de la Fuente L; Fernández S; Vázquez JA
    Rev Esp Quimioter; 2000 Jun; 13(2):182-6. PubMed ID: 10918092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro sensitivity of meningococci and the implications for prevention].
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Arch Belg Med Soc; 1973; 31(6):449-54. PubMed ID: 4205263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.